Benchmark indices has extended the morning gains on the back of possible US-China trade deal.
The Sensex is up 367.44 points at 38,960.96, while Nifty is up 116.80 points or 1.02% at 11,557. About 1042 shares have advanced, 460 shares declined, and 56 shares are unchanged.
Shares of GlaxoSmithKline Pharmaceuticals declined 5 percent in the early trade on September 26 after company suspended the distribution and supply of all dose forms of ranitidine hydrochloride products to all markets, including India, as a precautionary action pending the outcome of ongoing tests and investigations.
The Sensex is up 367.44 points at 38,960.96, while Nifty is up 116.80 points or 1.02% at 11,557. About 1042 shares have advanced, 460 shares declined, and 56 shares are unchanged.
Shares of GlaxoSmithKline Pharmaceuticals declined 5 percent in the early trade on September 26 after company suspended the distribution and supply of all dose forms of ranitidine hydrochloride products to all markets, including India, as a precautionary action pending the outcome of ongoing tests and investigations.
No comments:
Post a Comment